Last reviewed · How we verify
creatine supplementation
At a glance
| Generic name | creatine supplementation |
|---|---|
| Sponsor | University of Sao Paulo |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Any blood pressure related event
- Metabolic disturbance
- Any lipid related event
- Lipid drug interaction
- Hypokalemia
- Any glycemic related event
- Glycemic drug interaction
- Hyponatremia
- BP drug interaction
- Hyperkalemia
- Any aspirin related event
- Severe vomiting
Key clinical trials
- Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects (PHASE1)
- Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies (PHASE1)
- Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance (NA)
- Effect of Creatine Supplementation on Physical Performance in Vegan Subjects (NA)
- Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) (NA)
- Effects of Short-term Acute Creatine Supplementation on Power, Speed and Muscular Strengths in Young Football Players (NA)
- Effects of Creatine Supplementation on Cognitive Measures and Markers of Acute Kidney Injury After Exercise in the Heat (NA)
- Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- creatine supplementation CI brief — competitive landscape report
- creatine supplementation updates RSS · CI watch RSS
- University of Sao Paulo portfolio CI